Considering the strong association of SALL4 expression with tumor initiation and leukemia survival, our group recently explored its effects in the pathogenesis of leukemia mediated by MLL-AF9, −one of the most common MLL-r oncoproteins found in leukemia patients [69–71]. Here, KMT2A is linked to leukemia.